235 related articles for article (PubMed ID: 8353925)
1. Luminal narrowing after percutaneous transluminal coronary angioplasty. A study of clinical, procedural, and lesional factors related to long-term angiographic outcome. Coronary Artery Restenosis Prevention on Repeated Thromboxane Antagonism (CARPORT) Study Group.
Rensing BJ; Hermans WR; Vos J; Tijssen JG; Rutch W; Danchin N; Heyndrickx GR; Mast EG; Wijns W; Serruys PW
Circulation; 1993 Sep; 88(3):975-85. PubMed ID: 8353925
[TBL] [Abstract][Full Text] [Related]
2. Luminal narrowing after percutaneous transluminal coronary angioplasty. A multivariate analysis of clinical, procedural and lesion related factors affecting long-term angiographic outcome in the PARK study. Post-Angioplasty Restenosis Ketanserin.
Melkert R; Violaris AG; Serruys PW
J Invasive Cardiol; 1994 Jun; 6(5):160-71. PubMed ID: 10155065
[TBL] [Abstract][Full Text] [Related]
3. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
[TBL] [Abstract][Full Text] [Related]
4. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
[TBL] [Abstract][Full Text] [Related]
5. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty.
Foley DP; Melkert R; Serruys PW
Circulation; 1994 Sep; 90(3):1239-51. PubMed ID: 8087933
[TBL] [Abstract][Full Text] [Related]
6. Angiographic risk factors of luminal narrowing after coronary balloon angioplasty using balloon measurements to reflect stretch and elastic recoil at the dilation site. The CARPORT Study Group.
Rensing BJ; Hermans WR; Vos J; Beatt KJ; Bossuyt P; Rutsch W; Serruys PW
Am J Cardiol; 1992 Mar; 69(6):584-91. PubMed ID: 1536105
[TBL] [Abstract][Full Text] [Related]
7. Prevention of restenosis after coronary balloon angioplasty: rationale and design of the Fluvastatin Angioplasty Restenosis (FLARE) Trial. The FLARE Study Group.
Foley DP; Bonnier H; Jackson G; Macaya C; Shepherd J; Vrolix M; Serruys PW
Am J Cardiol; 1994 May; 73(14):50D-61D. PubMed ID: 8198025
[TBL] [Abstract][Full Text] [Related]
8. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
Hermans WR; Foley DP; Rensing BJ; Serruys PW
Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
[TBL] [Abstract][Full Text] [Related]
9. Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT).
Serruys PW; Rutsch W; Heyndrickx GR; Danchin N; Mast EG; Wijns W; Rensing BJ; Vos J; Stibbe J
Circulation; 1991 Oct; 84(4):1568-80. PubMed ID: 1833088
[TBL] [Abstract][Full Text] [Related]
10. Clinical and quantitative coronary angiographic predictors of coronary restenosis: a comparative analysis from the balloon-to-stent era.
Mercado N; Boersma E; Wijns W; Gersh BJ; Morillo CA; de Valk V; van Es GA; Grobbee DE; Serruys PW
J Am Coll Cardiol; 2001 Sep; 38(3):645-52. PubMed ID: 11527611
[TBL] [Abstract][Full Text] [Related]
11. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis.
Violaris AG; Melkert R; Serruys PW
Circulation; 1995 Apr; 91(8):2140-50. PubMed ID: 7697842
[TBL] [Abstract][Full Text] [Related]
12. Restenosis after delayed coronary angioplasty of the culprit vessel in patients with a recent myocardial infarction treated by thrombolysis.
Bauters C; Khanoyan P; McFadden EP; Quandalle P; Lablanche JM; Bertrand ME
Circulation; 1995 Mar; 91(5):1410-8. PubMed ID: 7867181
[TBL] [Abstract][Full Text] [Related]
13. Physiologic response to gain and loss in coronary minimal luminal diameter in patients treated with coronary angioplasty: prediction of restenosis on the basis of exercise capacity.
Jørgensen B; Simonsen S; Endresen K; Forfang K; Egeland T; Thaulow E
Am Heart J; 2000 Mar; 139(3):482-90. PubMed ID: 10689263
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors of restenosis after coronary stent placement.
Kastrati A; Schömig A; Elezi S; Schühlen H; Dirschinger J; Hadamitzky M; Wehinger A; Hausleiter J; Walter H; Neumann FJ
J Am Coll Cardiol; 1997 Nov; 30(6):1428-36. PubMed ID: 9362398
[TBL] [Abstract][Full Text] [Related]
15. Restenosis after coronary angioplasty for rapidly progressive coronary stenosis.
Bauters C; Passart F; Lablanche JM; McFadden EP; Hamon M; Bertrand ME
Eur Heart J; 1996 Nov; 17(11):1671-7. PubMed ID: 8922915
[TBL] [Abstract][Full Text] [Related]
16. Early luminal deterioration following successful percutaneous transluminal coronary angioplasty. Frequency, prediction and clinical implications.
Preisack MB; Athanasiadis A; Voelker W; Karsch KR
Eur Heart J; 1994 Jun; 15(6):739-46. PubMed ID: 8088261
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for early reocclusion and luminal renarrowing in patients with acute coronary syndromes treated by direct PTCA with provisional stenting.
Tölg R; Hartmann F; Adlar S; Kurz T; Kurowski V; Katus HA; Richardt G
Z Kardiol; 2000 Jun; 89(6):485-94. PubMed ID: 10929432
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic dissection after successful coronary balloon angioplasty: no influence on restenosis or on clinical outcome in 693 patients. The MERCATOR Study Group (Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
Hermans WR; Rensing BJ; Foley DP; Deckers JW; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
J Am Coll Cardiol; 1992 Oct; 20(4):767-80. PubMed ID: 1388181
[TBL] [Abstract][Full Text] [Related]
19. Frequency and efficacy of glycoprotein IIb/IIIa therapy for treatment of threatened or acute vessel closure in 1332 patients undergoing percutaneous transluminal coronary angioplasty.
Haase KK; Mahrholdt H; Schröder S; Baumbach A; Oberhoff M; Herdeg C; Karsch KR
Am Heart J; 1999 Feb; 137(2):234-40. PubMed ID: 9924156
[TBL] [Abstract][Full Text] [Related]
20. Six-month outcome after excimer laser coronary angioplasty for diffuse in-stent restenosis in native coronary arteries.
Hamburger JN; Foley DP; de Feyter PJ; Wardeh AJ; Serruys PW
Am J Cardiol; 2000 Aug; 86(4):390-4. PubMed ID: 10946030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
